Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionSevenBridge Financial Group, LLC
Latest Disclosed Ownership22,134 shares
Latest Disclosed Value $ 1,301,454
SevenBridge Financial Group, LLC reports 2.87% decrease in ownership of BRM / Bristol-Myers Squibb Company

On April 23, 2026 - SevenBridge Financial Group, LLC filed a 13F-HR form disclosing ownership of 22,134 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,160,264 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 22,789 shares of Bristol-Myers Squibb Company. This represents a change in shares of -2.87% during the quarter. The current value of the position is $1,049,816 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 22,134 -655 -2.87 1,301 4.58 0.2034
2026-02-02 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 22,789 -2,923 -11.37 1,244 -1.35 0.2001
2025-11-13 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 25,712 -4,682 -15.40 1,262 -10.82 0.2080
2025-09-04 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 30,394 -6,240 -17.03 1,415 -19.89 0.2494
2025-05-13 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 36,634 -7,482 -16.96 1,765 -28.46 0.3473
2025-02-12 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 44,116 -2,875 -6.12 2,468 -12.21 0.4668
2024-11-12 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 46,991 1,093 2.38 2,811 29.43 0.5415
2024-08-09 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 45,898 -1,626 -3.42 2,171 3.88 0.4802
2024-05-10 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 47,524 -3,675 -7.18 2,091 -20.41 0.4736
2024-01-22 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 51,199 -482 -0.93 2,627 -12.44 0.6206
2023-10-25 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 51,681 2,569 5.23 3,000 -4.49 0.7752
2023-07-26 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 49,112 797 1.65 3,141 -6.21 0.8109
2023-04-20 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 48,315 347 0.72 3,349 -2.98 0.9230
2023-01-26 2022-12-31 13F Bristol-Myers Squibb COM 110122108 47,968 1,117 2.38 3,451 3.60 1.0092
2022-10-17 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 46,851 13,404 40.08 3,331 29.36 1.1286
2022-07-12 2022-06-30 13F Bristol-Myers Squibb Equities 110122108 33,447 -601 -1.77 2,575 3.54 1.0412
2022-04-15 2022-03-31 13F Bristol-Myers Squibb COM 110122108 34,048 -5,287 -13.44 2,487 1.39 0.8731
2022-01-20 2021-12-31 13F/A-1 Bristol-Myers Squibb COM 110122108 39,335 -246 -0.62 2,453 4.74 0.7416
2021-10-14 2021-09-30 13F Bristol-Myers Squibb Equities 110122108 39,581 -150 -0.38 2,342 -11.79 0.7807
2021-07-26 2021-06-30 13F Bristol-Myers Squibb Equities 110122108 39,731 1,687 4.43 2,655 10.53 0.8656
2021-04-20 2021-03-31 13F Bristol-Myers Squibb Equities 110122108 38,044 2,072 5.76 2,402 7.66 0.8740
2021-01-19 2020-12-31 13F Bristol-Myers Squibb Equities 110122108 35,972 7,564 26.63 2,231 30.24 0.8721
2020-10-22 2020-09-30 13F Bristol-Myers Squibb Equities 110122108 28,408 8,231 40.79 1,713 44.44 0.7797
2020-07-24 2020-06-30 13F Bristol-Myers Squibb Equities 110122108 20,177 7,171 55.14 1,186 63.59 0.5890
2020-04-16 2020-03-31 13F Bristol-Myers Squibb Equities 110122108 13,006 4,157 46.98 725 27.64 0.4196
2020-01-17 2019-12-31 13F Bristol-Myers Squibb Equities 110122108 8,849 1,025 13.10 568 43.07 0.1484
2019-10-09 2019-09-30 13F Bristol-Myers Squibb Equities 110122108 7,824 -744 -8.68 397 2.06 0.2088
2019-07-15 2019-06-30 13F Bristol-Myers Squibb Equities 110122108 8,568 688 8.73 389 3.46 0.1393
2019-05-14 2019-03-31 13F Bristol-Myers Squibb Equities 110122108 7,880 467 6.30 376 -2.34 0.1411
2019-02-14 2018-12-31 13F Bristol-Myers Squibb Equities 110122108 7,413 -1,695 -18.61 385 -31.86 0.2356
2018-11-14 2018-09-30 13F Bristol-Myers Squibb Equities 110122108 9,108 192 2.15 565 14.60 0.3003
2018-08-14 2018-06-30 13F Bristol-Myers Squibb Equities 110122108 8,916 -350 -3.78 493 -15.87 0.2746
2018-05-11 2018-03-31 13F Bristol-Myers Squibb Equities 110122108 9,266 -243 -2.56 586 0.51 0.3362
2018-02-16 2017-12-31 13F Bristol-Myers Squibb Equities 110122108 9,509 67 0.71 583 -3.16 0.3224
2017-11-13 2017-09-30 13F Bristol-Myers Squibb Equities 110122108 9,442 750 8.63 602 24.38 0.3449
2017-08-14 2017-06-30 13F Bristol-Myers Squibb Common Stock 110122108 8,692 -9,961 -53.40 484 -51.41 0.2955
2017-05-15 2017-03-31 13F Bristol-Myers Squibb CS 110122108 18,653 10,674 133.78 996 148.38 0.6543
2017-02-03 2016-12-31 13F Bristol Myers Squibb CS 110122108 7,979 0 0.00 401 0.00 0.2912
2016-12-20 2016-09-30 13F/A-1 Bristol Myers Squibb CS 110122108 7,979 558 7.52 401 -26.56 0.2921
2016-11-28 2016-09-30 13F Bristol Myers Squibb CS 110122108 7,979 401
2016-08-15 2016-06-30 13F Bristol Myers Squibb CS 110122108 7,421 -52,818 -87.68 546 -42.10 0.3826
2016-06-27 2016-03-31 13F Bristol-Myers Squibb CS 110122108 60,239 60,239 943 0.0829
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.